Market Place
Sourcing Support
All News #Library
Others
Cytomed Therapeutics Seeks Shareholder Input On Value for Captial
13 Jan 2026 //
GLOBENEWSWIRE
Cytomed Bids Cash For TC Biopharma Assets Acquisition
14 Oct 2025 //
GLOBENEWSWIRE
CytoMed Therapeutics launches At-the-Market Offering Program
18 Aug 2025 //
GLOBENEWSWIRE
CytoMed Therapeutics Reports 2024 Financial Results & Updates
28 Apr 2025 //
GLOBENEWSWIRE
CytoMed Therapeutics Announces Chairman’s Letter to Shareholders
06 Feb 2025 //
GLOBENEWSWIRE
CytoMed & SunAct Collaborate On Gamma Delta T Cell Cancer Trial
06 Jan 2025 //
GLOBENEWSWIRE
CytoMed Buys Cord Blood License Via LongevityBank Unit
03 Oct 2024 //
GLOBENEWSWIRE
CytoMed Reports Financial Results For 6 Months Ended Jun 30
30 Sep 2024 //
GLOBENEWSWIRE
CytoMed Acquires Cord Blood Banking License For Cancer Therapy
17 Jul 2024 //
GLOBENEWSWIRE
CytoMed to Launch Complimentary Cell Banking for Future Precision Therapies
18 Mar 2024 //
GLOBENEWSWIRE
Malaysian Patent Granted for CytoMed`s Allogeneic Delta T Cell Technology
29 Jan 2024 //
GLOBENEWSWIRE
CytoMed Signs HOA and MOU to Advance Research on T Cell Technology
05 Dec 2023 //
PR NEWSWIRE
CytoMed Therapeutics Reports First Half 2023 Financial Report
17 Nov 2023 //
PR NEWSWIRE
CytoMed to Present at Benchmark Company`s Discovery Investor Conference
14 Nov 2023 //
PR NEWSWIRE
Chinese Patent Granted for CytoMed Therapeutics` Licensed iPSC-Based Technology
25 Sep 2023 //
PR NEWSWIRE
CytoMed announces collaboration with MD Anderson Cancer Center in US
11 May 2023 //
BIOSPECTRUM ASIA
CytoMed Therapeutics Limited Announces Collaboration with MD Anderson
09 May 2023 //
PR NEWSWIRE
CytoMed Therapeutics Limited Announces Pricing of Initial Public Offering
13 Apr 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.